<?xml version='1.0' encoding='utf-8'?>
<document id="23393498"><sentence text="Potential drug interactions in patients admitted to cardiology wards of a south Indian teaching hospital." /><sentence text="The potential drug-drug interaction (pDDI) increases as the number of concomitant medications increases" /><sentence text=" Patients with cardiovascular disorders are at higher risk for drug- drug interactions because of the types and number of drugs they receive" /><sentence text=" While drug interactions are reported to be common, there is no published report of the prevalence of such interactions among Indian cardiac patients" /><sentence text=" The aim of the present study was to identify the pattern of pDDI and document any observed interaction" /><sentence text=" It was also planned to evaluate the demography of patients and correlate it with the drug-drug interactions" /><sentence text="" /><sentence text="A prospective observational study from Oct 2007 to Apr 2008 was carried out in 'cardiology department' of a hospital in South India" /><sentence text=" Those patients who were taking at least two drugs and had a hospital stay of at least 48 hours were included in the study" /><sentence text=" The medications of the patients were analyzed for possible interactions" /><sentence text=" Factors associated with pDDI were studied" /><sentence text=" The actual interactions that were observed during the hospital stay in the study subjects were documented" /><sentence text="" /><sentence text="A total of 812 patients were included in the study" /><sentence text=" 388 pDDIs were identified among 249 patients" /><sentence text=" The incidence of pDDI was 30" /><sentence text="67%" /><sentence text=" The most common potential interactions were between aspirin &amp; heparin (29"><entity charOffset="53-60" id="DDI-PubMed.23393498.s18.e0" text="aspirin" /></sentence><sentence text="38%), and clopidogrel &amp; heparin (7"><entity charOffset="10-21" id="DDI-PubMed.23393498.s19.e0" text="clopidogrel" /></sentence><sentence text="21%)" /><sentence text=" Drug classes most commonly involved were antiplatelets, anticoagulants and diuretics" /><sentence text=" Majority of interactions were of moderate severity, delayed onset, and pharmacodynamic in nature" /><sentence text=" Total 68 actual interactions were observed in the observed cases" /><sentence text="" /><sentence text="The present study identified pDDIs and also documented interactions in cardiovascular patients" /><sentence text=" Factors which had correlation with adverse drug interactions were identified" /><sentence text=" This study highlights the need for screening prescriptions of cardiovascular patients for pDDIs and proactive monitoring of patients who have identified risk factors; this helps in detection and prevention of possible adverse drug interactions" /><sentence text="" /></document>